Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies


Por: Opladen, T, Lopez-Laso, E, Cortes-Saladelafont, E, Pearson, TS, Sivri, HS, Yildiz, Y, Assmann, B, Kurian, MA, Leuzzi, V, Heales, S, Pope, S, Porta, F, Garcia-Cazorla, A, Honzik, T, Pons, R, Regal, L, Goez, H, Artuch, R, Hoffmann, GF, Horvath, G, Thony, B, Scholl-Burgi, S, Burlina, A, Verbeek, MM, Mastrangelo, M, Friedman, J, Wassenberg, T, Jeltsch, K, Kulhanek, J and Hubschmann, OK

Publicada: 26 may 2020 Ahead of Print: 26 may 2020
Resumen:
Background Tetrahydrobiopterin (BH4) deficiencies comprise a group of six rare neurometabolic disorders characterized by insufficient synthesis of the monoamine neurotransmitters dopamine and serotonin due to a disturbance of BH4 biosynthesis or recycling. Hyperphenylalaninemia (HPA) is the first diagnostic hallmark for most BH4 deficiencies, apart from autosomal dominant guanosine triphosphate cyclohydrolase I deficiency and sepiapterin reductase deficiency. Early supplementation of neurotransmitter precursors and where appropriate, treatment of HPA results in significant improvement of motor and cognitive function. Management approaches differ across the world and therefore these guidelines have been developed aiming to harmonize and optimize patient care. Representatives of the International Working Group on Neurotransmitter related Disorders (iNTD) developed the guidelines according to the SIGN (Scottish Intercollegiate Guidelines Network) methodology by evaluating all available evidence for the diagnosis and treatment of BH4 deficiencies. Conclusion Although the total body of evidence in the literature was mainly rated as low or very low, these consensus guidelines will help to harmonize clinical practice and to standardize and improve care for BH4 deficient patients.

Filiaciones:
Opladen, T:
 Univ Childrens Hosp, Div Child Neurol & Metab Disorders, Heidelberg, Germany

Lopez-Laso, E:
 Univ Hosp Reina Sofia, IMIBIC, Dept Pediat, Pediat Neurol Unit, Cordoba, Spain

 CIBERER, Cordoba, Spain

:
 Inst Recerca St Joan Deu, Inborn Errors Metab Unit, Barcelona, Spain

 CIBERER ISCIII, Barcelona, Spain

 Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Pediat, Unit Pediat Neurol & Metab Disorders, Badalona, Spain

 Univ Autonoma Barcelona, Fac Med, Badalona, Spain

Pearson, TS:
 Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

Sivri, HS:
 Hacettepe Univ, Fac Med, Dept Pediat, Metab Sect, TR-06100 Ankara, Turkey

Yildiz, Y:
 Hacettepe Univ, Fac Med, Dept Pediat, Metab Sect, TR-06100 Ankara, Turkey

Assmann, B:
 Univ Childrens Hosp, Div Child Neurol & Metab Disorders, Heidelberg, Germany

Kurian, MA:
 UCL Great Ormond St Inst Child Hlth, Dev Neurosci, London, England

 Great Ormond St Hosp Sick Children, Dept Neurol, London, England

Leuzzi, V:
 Sapienza Univ Rome, Dept Human Neurosci, Unit Child Neurol & Psychiat, Rome, Italy

Heales, S:
 Natl Hosp, Neurometab Unit, Queen Sq, London, England

Pope, S:
 Natl Hosp, Neurometab Unit, Queen Sq, London, England

Porta, F:
 AOU Citta Salute & Sci, Dept Pediat, Turin, Italy

Garcia-Cazorla, A:
 Inst Recerca St Joan Deu, Inborn Errors Metab Unit, Barcelona, Spain

 CIBERER ISCIII, Barcelona, Spain

Honzik, T:
 Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Prague, Czech Republic

 Gen Univ Hosp, Prague, Czech Republic

Pons, R:
 Univ Athens, Aghia Sofia Hosp, Dept Pediat 1, Athens, Greece

Regal, L:
 UZ Brussel, Dept Pediat, Pediat Neurol & Metab Unit, Brussels, Belgium

Goez, H:
 Univ Alberta, Glenrose Rehabil Hosp, Dept Pediat, Edmonton, AB, Canada

Artuch, R:
 CIBERER, Inst Recerca St Joan de Deu, Dept Clin Biochem, Barcelona, Spain

 MetabERN Hosp St Joan de Deu, Barcelona, Spain

Hoffmann, GF:
 Univ Childrens Hosp, Div Child Neurol & Metab Disorders, Heidelberg, Germany

Horvath, G:
 Univ British Columbia, Div Biochem Genet, BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada

Thony, B:
 Univ Childrens Hosp Zurich, Div Metab, Zurich, Switzerland

Scholl-Burgi, S:
 Med Univ Innsbruck, Clin Pediat 1, Anichstr 35, Innsbruck, Austria

Burlina, A:
 Azienda Osped Univ Padova, Dipartimento Salute Donna & Bambino, UOC Malattie Metabol Ereditarie, Campus Biomed Pietro Abano, Padua, Italy

Verbeek, MM:
 Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Alzheimer Ctr,Med Ctr, Nijmegen, Netherlands

 Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Lab Med, Alzheimer Ctr,Med Ctr, Nijmegen, Netherlands

Mastrangelo, M:
 Sapienza Univ Rome, Dept Human Neurosci, Unit Child Neurol & Psychiat, Rome, Italy

Friedman, J:
 Rady Childrens Hosp, Div Neurol, UCSD Dept Neurosci, San Diego, CA USA

 Rady Childrens Hosp, Div Neurol, UCSD Dept Pediat, San Diego, CA USA

 Rady Childrens Inst Genom Med, San Diego, CA USA

Wassenberg, T:
 UZ Brussel, Dept Pediat, Pediat Neurol & Metab Unit, Brussels, Belgium

Jeltsch, K:
 Univ Childrens Hosp, Div Child Neurol & Metab Disorders, Heidelberg, Germany

Kulhanek, J:
 Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Prague, Czech Republic

 Gen Univ Hosp, Prague, Czech Republic

Hubschmann, OK:
 Univ Childrens Hosp, Div Child Neurol & Metab Disorders, Heidelberg, Germany
ISSN: 17501172





Orphanet Journal of Rare Diseases
Editorial
BioMed Central, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Review
Volumen: 15 Número: 1
Páginas: 126-126
WOS Id: 000537854200002
ID de PubMed: 32456656
imagen Green Accepted, Green Published, gold

MÉTRICAS